These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6334738)

  • 1. Seroreactivity in myositis patients.
    Reichlin M
    J Rheumatol; 1984 Oct; 11(5):591-2. PubMed ID: 6334738
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies to intracellular antigens, with particular reference to transfer RNA and related proteins in myositis.
    Bernstein RM; Mathews MB
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():83-8. PubMed ID: 2441048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen.
    Treadwell EL; Alspaugh MA; Wolfe JF; Sharp GC
    J Rheumatol; 1984 Oct; 11(5):658-62. PubMed ID: 6334745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to defined antigens in the systemic rheumatic diseases.
    Reichlin M
    Bull Rheum Dis; 1993 Dec; 42(8):4-6. PubMed ID: 8173650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa.
    Kajihara M; Kuwana M; Tokuda H; Yamane K; Kubo M; Hirakata M; Mimori T
    J Rheumatol; 2000 Nov; 27(11):2707-10. PubMed ID: 11093458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological reactions to articular cartilage and synovial membrane antigens in osteoarthrosis deformans].
    Mazina NM; Taratuta OV
    Vopr Revm; 1979; (4):14-8. PubMed ID: 524794
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies in systemic rheumatic disorders clinical and diagnostic relevance.
    Genth E; Mierau R
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):149S-152S. PubMed ID: 9385666
    [No Abstract]   [Full Text] [Related]  

  • 8. Do autoantibodies inhibit function of their cognate antigens in vivo?
    Tan EM
    Arthritis Rheum; 1989 Jul; 32(7):924-5. PubMed ID: 2751724
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen.
    Hengstman GJ; Vree Egberts WT; Seelig HP; Lundberg IE; Moutsopoulos HM; Doria A; Mosca M; Vencovsky J; van Venrooij WJ; van Engelen BG
    Ann Rheum Dis; 2006 Feb; 65(2):242-5. PubMed ID: 16410528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial blot assays in the diagnosis of systemic rheumatic diseases.
    Ghirardello A; Bendo R; Rampudda ME; Bassi N; Zampieri S; Doria A
    Autoimmun Rev; 2009 Jul; 8(8):645-9. PubMed ID: 19393203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heterophilic antibodies to connective tissue antigens in rheumatism patient serum do not appear to cross react with streptococcal group A antigens].
    Danilova TA
    Biull Eksp Biol Med; 1994 Jun; 117(6):642-4. PubMed ID: 8068925
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoimmunity in rheumatism].
    Liampert IM
    Vopr Revm; 1977; (4):68-75. PubMed ID: 305154
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations.
    Hengstman GJ; van Engelen BG; van Venrooij WJ
    Curr Opin Rheumatol; 2004 Nov; 16(6):692-9. PubMed ID: 15577606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Auto-allergic processes in patients with a lesion of the nervous system in various collagenosis].
    Man'kovskiĭ NB; Kazakevich RL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1123-9. PubMed ID: 5303865
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological aspects of polymyositis].
    Takayanagi T; Honda H
    No To Shinkei; 1983 Jun; 35(6):525-33. PubMed ID: 6354219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
    Genth E; Mierau R
    Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies to extractable nuclear antigens in systemic lupus erythematosus].
    Ivanova SM; Alekberova ZS; Preobrazhenskiĭ DV; Speranskiĭ AI
    Ter Arkh; 1982; 54(6):54-7. PubMed ID: 7112420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.